1 not yet recruiting, 1 recruiting. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Not yet recruiting 1, Recruiting 1 |
Follow Cerebrovascular Event: new trials by email Literature Review of Cerebrovascular Event trials Research Report on Cerebrovascular Event
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Methylprednisolone After Flow-Diverter Stent Implantation in Unruptured Intracranial Aneurysms Methylprednisolone (Injectable Form), Placebo Injection - Unruptured Intracranial Aneurysms, Cerebrovascular Event | Phase 4 | Not yet recruiting | Duan Chuanzhi | 864 | 2026-11-30 | 2026-10-26 |
| Atorvastatin Pretreatment in Cerebrovascular Events (APICES) After Flow Diverter Implantation Atorvastatin 20mg - Cerebrovascular Event, Stent Stenosis | Phase 4 | Recruiting | Duan Chuanzhi | 354 | 2024-07-30 | 2026-03-03 |
Hemorrhagic Stroke (2) · Intracranial Aneurysm (2) · Brain Death (1) · Ischemic Stroke (1) · Stroke (1)
Aneurysm (2) · Brain Diseases (2) · Cardiovascular Diseases (2) · Central Nervous System Diseases (2) · Cerebrovascular Disorders (2) · Intracranial Arterial Diseases (2) · Nervous System Diseases (2) · Vascular Diseases (2) · Coma (1) · Consciousness Disorders (1) · Death (1) · Neurobehavioral Manifestations (1) · Neurologic Manifestations (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Atorvastatin (1) · Methylprednisolone (1)
Duan Chuanzhi (2)
China (2)
Chuanzhi Duan (1) · Chuanzhi Duan, MD (1)
PMID 10634801, PMID 11498461, PMID 22472556, PMID 24462073, PMID 25355814, PMID 26590269, PMID 29146831, PMID 29327999, PMID 30565953, PMID 31352800, PMID 31504418, PMID 33447904, PMID 34991791, PMID 35292570, PMID 36375835, PMID 36700744, PMID 37324979, PMID 38198155, PMID 38719444